Superior vena cava syndrome caused by chemotherapy-induced fibrosis

Journal of Chemotherapy

Volumn 14, Issue 4, 2002, Pages 417-419

  Turk, H M ^a   Camci, C ^a   Buyukberber, Süleyman ^a   Tuncozgur, B ^a   Sivrikoz, C ^a   Elbeyli, L ^a   Sari, I ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Fibrosis; Superior vena cava syndrome

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; BRACHIOCEPHALIC VEIN; BRONCHUS BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE COURSE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LUNG FIBROSIS; LUNG SMALL CELL CANCER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; SUPERIOR CAVA VEIN SYNDROME; THORAX SURGERY; TREATMENT OUTCOME; TUMOR REGRESSION;

EID: 0036692592     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.4.417     Document Type: Article

References (8)

1. A reassessment of the clinical implications of the superior vena caval syndrome
2. Superior vena caval obstruction: Is it a medical emergency?
3. Mediastinoscopy in advanced superior vena cava obstruction
4. Superior vena caval obstruction syndrome in small cell lung cancer
5. Radiation-induced and chemotherapy-induced pulmonary injury
6. Tumor regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment
7. FTS reduces bleomycin-induced cytokine and chemokine production and inhibits pulmonary fibrosis in mice
8. Intravascular stents in the management of superior vena cava syndrome